LRP1 and diabetes mellitus: Although previous reports have evaluated the effect of pioglitazone on LRP1 expression in the brain using animal models, those mouse models had metabolic features of diabetes; thus, it was difficult to exclude the anti-diabetic effect of pioglitazone from the results50,51.